BIOTHERYX
BioTheryX focuses on the development of therapies for hematological malignancies. It intends to leverage its extensive experience and proven commercial success to deliver efficacious therapies to patients with unmet medical needs more quickly and less expensively than the biomedical industry traditionally can and does. To do so, they are exploiting enhanced biology-driven models to identify effective core molecules that can be rapidly exploited using focused and prioritized chemistry approaches coupled with clinically proven translational approaches targeted for cancer and immune dysfunction. The company was founded in 2007 and is headquartered in Chappaqua, New York.
BIOTHERYX
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2007-01-01
Address:
Chappaqua, New York, United States
Country:
United States
Website Url:
http://www.biotheryx.com
Total Employee:
51+
Status:
Active
Contact:
(914) 490-5425
Email Addresses:
[email protected]
Total Funding:
128.65 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Domain Not Resolving Wordpress Plugins
Current Advisors List
Current Employees Featured
Founder
Investors List
Deep Track Capital
Deep Track Capital investment in Series E - BioTheryX
Lumira Ventures
Lumira Ventures investment in Series E - BioTheryX
SR One
SR One investment in Series E - BioTheryX
Janus Henderson Investors
Janus Henderson Investors investment in Series E - BioTheryX
Rock Springs Capital
Rock Springs Capital investment in Series E - BioTheryX
Farallon Capital Management
Farallon Capital Management investment in Series E - BioTheryX
Point72
Point72 investment in Series E - BioTheryX
Alexandria Venture Investments
Alexandria Venture Investments investment in Series E - BioTheryX
Tekla Capital Management
Tekla Capital Management investment in Series E - BioTheryX
Irving Investors
Irving Investors investment in Series E - BioTheryX
Key Employee Changes
Official Site Inspections
http://www.biotheryx.com Semrush global rank: 4.31 M Semrush visits lastest month: 2.65 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "BioTheryX"
About Us – Biotheryx
Biotheryx is a biopharmaceutical company discovering and developing a portfolio of first-in-class protein degraders, including bifunctional degraders and molecular glues.Our focus is deploying …See details»
Biotheryx - Crunchbase Company Profile & Funding
Organization. Biotheryx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Biotheryx is a clinical …See details»
BioTheryX Company Profile | Management and Employees List
BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition to …See details»
BioTheryx 2025 Company Profile: Valuation, Funding
BioTheryx General Information Description. Operator of a clinical-stage biopharmaceutical company intended to develop treatments to recover from …See details»
Biotheryx - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
BioTheryX Company Profile - Office Locations, Competitors ... - Craft
BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis through protein modulation. Its principal technology platform centers on targeted …See details»
BIOTHERYX, INC. - VentureRadar
" BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition to …See details»
BIOTHERYX, INC. Company Profile | San Diego, CA | Competitors ...
Find company research, competitor information, contact details & financial data for BIOTHERYX, INC. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
BioTheryX - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 24, 2025 Biotheryx Announces U.S. FDA Clearance of Investigational New Drug Application for BTX-9341, a First-In-Class, Dual Bifunctional Degrader of CDK4/6BioSpace • May 07, …See details»
2021 - Biotheryx
Oct 28, 2021 About BioTheryX, Inc. BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis, including protein degradation and modulation, and …See details»
Biotheryx - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Biotheryx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... About. Biotheryx has 3 current employee profiles, …See details»
BioTheryX - Overview, News & Similar companies | ZoomInfo.com
Who is BioTheryX. BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition …See details»
BioTheryX, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Biotheryx’s clinical program, BTX-9341, a bifunctional degrader of CDK4 and CDK6, began a Phase 1 clinical trial in the third quarter of 2024. Biotheryx’s pipeline also includes BTX-10908, …See details»
BioTheryX - Raised $133M Funding from 13 investors - Tracxn
5 days ago BioTheryX has raised a total funding of $133M over 8 rounds from 13 investors. Investors include Tekla Capital Management, Rock Springs Capital and 11 others. Their latest …See details»
BIOTHERYX, INC. - VentureRadar
BioTheryX is a clinical-stage biopharmaceutical company focused on restoring protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition to …See details»
Left out of SPAC pack, BioTheryX raises $92M in rare series E to …
May 21, 2021 BioTheryX hauled a $92 million series E on Thursday led by Farallon Capital Management with backing from nearly a dozen other new investors and participation from …See details»
BioTheryX Company Profile, Stock Price, News, Rankings - Fortune
Biotheryx is a rare find and truly encompasses the title Great Place to Work." Read the Great Place To Work Review. Courtesy of BioTheryX. Company Information Company Info.See details»
BioTheryX Announces $92M Series E Financing to Accelerate …
SAN DIEGO, May 20, 2021 /PRNewswire/ — BioTheryX, Inc., a clinical-stage company focused on degrading proteins to create life-saving cancer medicines, today announced a $92 million …See details»
Degrading proteins, creating life-saving medicines - Nature
BioTheryX is a results-oriented biotechnology company whose mission is to create novel therapeutics by degrading disease-causing proteins. The company’s founders are scientific …See details»
Culture Biosciences unveils Stratyx™ 250, the first cloud
4 hours ago /CNW/ -- Culture Biosciences, a leader in cloud-based biomanufacturing, announced the launch of Stratyx™ 250, the first mobile, cloud-integrated bioreactor...See details»